MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10428194.2023.2191152

Медицинская библиотека · Leukemia & lymphoma · 2023

EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.

Agrawal Prashasti, David Kevin A, Chen Zhengming, Sundaram Suchitra, Kim Seo-Hyun, Vaca Ryan, Lin Yong, Singer Samuel, Malecek Mary-Kate, Carter Jordan, Zayac Adam, Kim Myung Sun, Reddy Nishitha, Ney Douglas, Habib Alma, Strouse Christopher, Graber Jerome, Bachanova Veronika, Salman Sidra, Vendiola Jean A, Hossain Nasheed, Tsang Mazie, Major Ajay, Gandhi Maher K, Keane Colm, Bond David A, Folstad Matthew, Chang Julie, Mier-Hicks Angel, Torka Pallawi, Rajakumar Priya, Venugopal Parameswaran, Berg Stephanie, Glantz Michael, Goldlust Samuel A, Matnani Rahul, Kumar Pallavi, Ollila Thomas A, Cai Johnny, Spurgeon Stephen E, Sieg Alex G, Cleveland Joseph, Epperla Narendranath, Karmali Reem, Naik Seema, Smith Sonali M, Rubenstein James L, Kahl Brad S, Chadburn Amy, Evens Andrew M, Martin Peter

Многоцентровое исследованиеСтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

The objective of this multicenter retrospective study was to examine the incidence, patient characteristics, pathology, and outcomes associated with Epstein-Barr virus (EBV)-related CNS lymphoma (CNSL) in older patients. Among 309 CNSL patients aged ≥60, 11.7% had EBV + tumors of which 72.2% were solid organ transplant (SOT)-related post-transplant lymphoproliferative disorders (PTLD). Younger age, SOT or autoimmune disease, and immunosuppressive treatment correlated highly with EBV-positivity. EBV + tumors were associated with absent C-MYC and BCL6 expression. EBV + PTLD was more likely to be associated with the absence of CD5 expression. EBV + non-PTLD had better median OS (not reached) compared to EBV + PTLD (10.8 months) and EBV-negative patients (43 months). Multivariable Cox regression analysis showed that age, performance status, and PTLD were negative predictors of OS. EBV status and immunosuppressive treatment were not correlated with OS. Our findings merit further investigation of EBV + PCNSL tumors and EBV-directed therapies.

Для цитирования: Agrawal Prashasti, David Kevin A, Chen Zhengming, Sundaram Suchitra, Kim Seo-Hyun, Vaca Ryan, Lin Yong, Singer Samuel, Malecek Mary-Kate, Carter Jordan, Zayac Adam, Kim Myung Sun, Reddy Nishitha, Ney Douglas, Habib Alma, Strouse Christopher, Graber Jerome, Bachanova Veronika, Salman Sidra, Vendiola Jean A, Hossain Nasheed, Tsang Mazie, Major Ajay, Gandhi Maher K, Keane Colm, Bond David A, Folstad Matthew, Chang Julie, Mier-Hicks Angel, Torka Pallawi, Rajakumar Priya, Venugopal Parameswaran, Berg Stephanie, Glantz Michael, Goldlust Samuel A, Matnani Rahul, Kumar Pallavi, Ollila Thomas A, Cai Johnny, Spurgeon Stephen E, Sieg Alex G, Cleveland Joseph, Epperla Narendranath, Karmali Reem, Naik Seema, Smith Sonali M, Rubenstein James L, Kahl Brad S, Chadburn Amy, Evens Andrew M, Martin Peter. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.. Leukemia & lymphoma. 2023. DOI: 10.1080/10428194.2023.2191152.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.